Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Exchange Rate Effect of $22000.0 for Q1 2026, up 130.14% on a QoQ basis from -$73000.0 in Q4 2025, and up 2300.0% year-over-year from $916.67 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Exchange Rate Effect history runs 16 years deep, the most recent figure standing at $22000.0 for Q1 2026.
- Quarterly Exchange Rate Effect rose 2300.0% year-over-year to $22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7000.0 (down 75.0% YoY) and the FY2025 annual result came in at -$30000.0, down 650.0% from the prior year.
- Exchange Rate Effect was $22000.0 for Q1 2026 at Oramed Pharmaceuticals, up from -$73000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $40000.0 in Q2 2025 and bottomed at -$105000.0 in Q4 2022.
- A 5-year average of -$9562.5 and a median of $1000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect slumped 3550.0% — and 2026, when it soared 2300.0%.
- Oramed Pharmaceuticals' Exchange Rate Effect stood at -$105000.0 in 2022, then jumped by 107.62% to $8000.0 in 2023, then sank by 125.0% to -$2000.0 in 2024, then slumped by 3550.0% to -$73000.0 in 2025, then soared by 130.14% to $22000.0 in 2026.
- Business Quant data shows ORMP's Exchange Rate Effect at $22000.0 in Q1 2026, -$73000.0 in Q4 2025, and $4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |